Tag: NASDAQ: SLRX

Business

Salarius Pharmaceuticals Inc (NASDAQ: SLRX) in the Green Zone Over Key Clinical Findings

Salarius Pharmaceuticals Inc (NASDAQ: SLRX) exited yesterday at $1.22, up 0.83%. SLRX has been in the green zone for a long time, and here’s why.  Investors responding well to key findings from seclidemstat’s clinical research SLRX, the clinical-stage biopharmaceutical company, is known for developing treatments for cancers, solid tumors, and […]